T cell receptor recognizing tetanus toxoid-derived peptides (TT-specific TCR)

The T cell receptor (TCR) recognizing tetanus toxoid-derived peptides is a specialized heterodimeric protein complex expressed on the surface of CD4+ helper T lymphocytes (Source: UniProt). Its primary biological function is the specific recognition of processed peptides from the Clostridium tetani toxin when they are presented by Major Histocompatibility Complex class II (MHC-II) molecules on antigen-presenting cells (Source: PubMed PMID: 25231505). Upon binding to these peptide-MHC complexes, the TCR initiates a signaling cascade through the CD3 complex, leading to T cell activation, proliferation, and the secretion of cytokines such as IL-2 and IFN-gamma (Source: Janeway's Immunobiology). This activation is essential for orchestrating the adaptive immune response, including the stimulation of B cells to produce protective antibodies against the tetanus toxin (Source: CDC). In clinical practice, this receptor is the primary target of tetanus toxoid vaccines, which aim to establish a pool of long-lived memory CD4+ T cells to provide immunity (Source: NIH). These TCRs are also utilized as critical research tools and biomarkers to evaluate immune competence and vaccine efficacy through assays like ELISpot and MHC-tetramer staining (Source: Frontiers in Immunology, 2020).

Other names

Tetanus toxoid-specific T-cell receptorTT-specific CD4+ TCRTetanus toxoid-reactive TCRCD4+ TCR (tetanus toxoid)

Recognition of tetanus toxoid peptides presented by MHC class II molecules, leading to T cell activation and memory formation (Source: PubMed PMID: 25231505).